LPCN·53630X203·US·equity·Healthcare - Biotechnology-13D/G
LPCN (LIPOCINE INC NEW) is held by 22 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($713,283), GEODE CAPITAL MANAGEMENT, LLC ($504,741), RENAISSANCE TECHNOLOGIES LLC ($307,591). Net institutional sentiment: Mixed.
See how LPCN's score breaks down across 4 SEC sources
Showing 1-20 of 23
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer